Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
fixed-dose combination medication |
| gptkbp:activeIngredient |
gptkb:rilpivirine
emtricitabine tenofovir disoproxil |
| gptkbp:approvalYear |
2011
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AR08
|
| gptkbp:contraindication |
severe renal impairment
concurrent use with rifampin concurrent use with certain anticonvulsants |
| gptkbp:drugClass |
antiretroviral therapy
protease inhibitor non-nucleoside reverse transcriptase inhibitor |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Complera
|
| gptkbp:indication |
treatment of HIV-1 infection in adults
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Gilead_Sciences
|
| gptkbp:mechanismOfAction |
inhibits HIV reverse transcriptase
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:depression
nausea dizziness headache rash insomnia |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:rilpivirine
|
| gptkbp:bfsLayer |
6
|